American Portfolios Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
RP
BG
American Portfolios Advisors's AMED Position: Q2 2022 in Review
American Portfolios Advisors sold out of Amedisys (AMED) in Q2 2022, closing a stake of 14 shares — an estimated $2.41K sold.
American Portfolios Advisors first reported a position in AMED in Q1 2021 and held it in 3 quarters. The position peaked at $20.1K in Q1 2021. 289 funds tracked by Wall St. Rank hold AMED as of Q2 2022.
- American Portfolios Advisors reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
- American Portfolios Advisors sold 14 Amedisys shares in Q2 2022, an estimated $2.41K.
- American Portfolios Advisors first reported a position in Amedisys in Q1 2021 and held it in 3 quarters.
- American Portfolios Advisors's Amedisys position peaked at $20.1K in Q1 2021.
- 289 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.
Based on American Portfolios Advisors's 13F filing for Q2 2022, filed 20 Mar 2023.